Effect of COVID-19 pandemic on stroke admissions and quality of stroke interventional treatment in Masovian Voivodeship by Dębiec, Aleksander et al.
223www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Neurologia i Neurochirurgia Polska
Polish Journal of Neurology and Neurosurgery
2021, Volume 55, no. 2, pages: 223–226
DOI: 10.5603/PJNNS.a2021.0025
Copyright © 2021 Polish Neurological Society 
ISSN: 0028-3843, e-ISSN: 1897-4260
SHORT COMMUNICATION
Address for correspondence: Aleksander Dębiec, Clinic of Neurology, Military Institute of Medicine, Szaserow 128 Str., 04-141 Warsaw, Poland,  
e-mail: adebiec@wim.mil.pl
Effect of COVID-19 pandemic on stroke admissions 
and quality of stroke interventional treatment  
in Masovian Voivodeship
Aleksander Dębiec1, Marta Bilik2, Piotr Piasecki3, Adam Stępień1, Jacek Staszewski1
1Clinic of Neurology, Military Institute of Medicine, Warsaw, Poland 
2Department of Neurology with Stroke Unit, John Paul II Western Hospital, Grodzisk Mazowiecki, Poland 
3Department of Interventional Radiology, Military Institute of Medicine, Warsaw, Poland
ABSTRACT
Aim of study. To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on the pathway of stroke interven-
tional services and major quality indicators of stroke reperfusion therapies in Masovian Voivodeship.
Materials and methods. An exploratory retrospective analysis was performed at two comprehensive stroke centres to assess 
changes in stroke care between the early phase of the COVID-19 pandemic (weeks 10–18 of 2020) and the same period in 2019.
Results. Of the 419 included stroke patients, 186 (44.4%) presented during the COVID-19 period. There was an increase in 
in-hospital delays for reperfusion therapies, and a significant decrease in the number of acute cerebrovascular accident admis-
sions, predominantly related to a low number of transient ischaemic attack (TIA) admissions to hospital (-20.17%). The delays 
were shorter in the mothership paradigm than in the drip-and-ship paradigm of acute stroke care (onset-to-groin 293 vs. 232 
min, p = 0.03). No differences in stroke aetiology, large-vessel occlusion frequency, or severe stroke admissions in the COVID-19 
period were observed.
Conclusions and clinical implications. COVID-19’s emergence was correlated with a significant reduction in admissions to 
stroke departments, particularly for TIAs, and a prolonged delay in reperfusion stroke treatment, especially in the drip-and-ship 
paradigm. An educational campaign to raise public awareness of TIA and/or stroke symptoms and immediate reorganisation 
of stroke care during the COVID-19 era are necessary.
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Introduction
The World Stroke Organisation has identified a marked fall in 
stroke presentations and a widespread impact of the coronavirus 
2019 (COVID-19) pandemic on stroke services, with reduced eval-
uations and admissions for stroke during the first half of 2020 [1]. 
Despite the potential consequences of untreated or undi-
agnosed strokes, patients are less willing to seek medical care. 
This is related to the call for social distancing and increased 
use of remote teleconsultations recommended by the Polish 
Ministry of Health instead of face-to-face meetings [2, 3]. The 
pandemic has required drastic changes in resource allocation, 
which can affect stroke care delivery. Knowledge of the gaps in 
the stroke interventional service pathway is important because 
of the great impact of delays on stroke outcome. Reports of 
the effect of COVID-19 on Polish health services in acute 
cerebrovascular accidents are lacking.
Methods
The aim of this study was to assess the impact of the 
COVID-19 pandemic on the stroke interventional service 
pathway and care quality indicators for stroke management. 
In this exploratory retrospective analysis, we collected data 
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on the number of consecutive hospital admissions of adults 
aged 18-plus admitted due to a final diagnosis of acute cere-
brovascular accident (ischaemic stroke, haemorrhagic stroke, 
subarachnoid haemorrhage (SAH) and transient ischaemic 
attack [TIAs]), stroke subtypes (using the TOAST classifi-
cation), reperfusion therapies and stroke quality measures 
(door-to-needle [DTN], door-to-computed tomography 
[DTCT], door-to-groin [DTG], onset-to-groin [OTG], effec-
tive recanalisation [TICI 2b or 3], and 30-day mortality rate). 
Data was collected from two comprehensive stroke centres 
(CSCs) covering majority of interventional stroke services for 
Masovian Voivodeship that serve as referral bases for 15 pri-
mary stroke centres in this region, which has a population of 
800,000, and included all patients hospitalised in weeks 10 to 
18 of 2020 (the initial COVID-19 period) and the same period 
in 2019 (the pre-COVID-19 period). 1 March 2020 (week 10) 
was selected as the start date of the COVID-19 period, as this 
was the date when the first patient developed COVID-19 symp-
toms with serological confirmation of SARS-CoV-2 infection. 
On 20 March  2020, Poland was placed into lockdown by 
government, but social distancing and the cancellation of 
scheduled hospital admissions had been encouraged since 
the beginning of March. The number of stroke/TIA cases is 
presented as cases/100,000 inhabitants, and the population 
was assumed to remain stable from 2019 to 2020 because the 
change in population in recent years has been small, and no 
mass migration from cities was observed. Data was compared 
by univariate analysis using the Wilcoxon-Mann-Whitney test 
and 2-tailed Fisher’s exact test using PQStat software. Differenc-
es with p values < 0.05 were considered statistically significant.
Results
Of the 419 included patients, 186 (44.4%) presented in the 
COVID-19 period (Tab. 1). There was a significant decrease 
in the number of acute cerebrovascular accident admissions 
(-20.17%) between the pre-COVID-19 and COVID-19 peri-
ods, which was related to the low number of TIA admissions, 
especially in weeks 12, 13 and 17 (Fig. 1). There were no dif-
ferences in stroke aetiology, the frequency of large-vessel oc-
clusions, severe stroke admissions, or reperfusion procedures 
between 2020 and 2019. However, major delays (DTCT, DTN, 
DTG, and OTG) in patients receiving reperfusion treatment 
significantly increased during the COVID-19 period. There 
was also a significant increase in OTG time for patients treated 
in a drip-and-ship model compared to that for patients treated 
with the mothership paradigm (293 vs. 232 min, p = 0.03). The 
30-day mortality rates and functional outcomes were similar 
in the COVID-19 and pre-COVID-19 periods.
Discussion
We conducted an exploratory analysis to estimate the 
change in the number of new stroke diagnoses in our region, 
and to evaluate the impact of the COVID-19 pandemic on 
major stroke quality measures. 
Our study showed that the stroke care system in the Maso-
vian Voivodeship was significantly affected by COVID-19, with 
a 20% decrease in acute cerebrovascular accident admissions. 
The World Stroke Organisation reported a global reduction of 
42% in acute cerebrovascular accident admissions [4]. A re-
cent paper revealed a decrease in general stroke admissions 
of 19.4% and a reduction in stroke unit admissions of 24.6% 
from January to May 2020 compared to the same months in 
2019 in Malopolska Voivodeship. Moreover, the number of 
patients treated with interventional services declined during 
the COVID-19 pandemic [-32% for intravenous recombinant 
tissue plasminogen activator (rtPA) and -25% for mechanical 
thrombectomy] compared to the previous year. The exact fig-
ures, including stroke quality measures, were not provided [5].
Decreases in the number of acute stroke admissions could 
be caused by fear of COVID-19. Strict social distancing rules 
persuaded patients to avoid face-to-face medical consultation. 
Additionally, isolation could also have an impact through 
reducing the chance of another individual noticing stroke 
symptoms [2]. The decrease in the number of admissions to 
stroke departments during the COVID-19 pandemic observed 
in our study was mainly related to fewer admissions due to 
TIAs. TIA patients have a high short-term risk of developing 
ischaemic stroke, especially within the first 48 hours, so a pub-
lic education campaign raising awareness of stroke as well as 
TIA signs, the need for timely diagnosis, and urgent preventive 
treatment, are all essential to reduce this risk.
The major problems revealed in our study involved 
pre- and in-hospital delays. Factors causing delays were the 
COVID-19 screening process and the reallocation of medical 
staff and protective equipment to COVID-19 care, which led 
to a shortage of resources at non-COVID hospitals and an 
inability to create or maintain fast-track stroke-care channels 
[2]. Moreover, healthcare professionals faced physical and 
mental pressure due to the continuously high risk of SARS-
CoV-2 infection and were overworked because of quarantined 
or relocated colleagues [6, 7]. 
COVID-19 testing should not cause any impact on or delay 
to stroke diagnostics or treatment. Therefore, some authors 
have suggested the addition of chest CT to standard stroke 
protocols, which could identify pulmonary COVID-19 com-
plications, and/or the implementation of fast screening, for 
example rapid antigen testing for SARS-CoV-2, the results of 
which may be later confirmed with RT-PCR testing. Further-
more, every patient must be treated as potentially infected and 
wear a mask throughout the whole diagnostic pathway, with 
the exception of a facial nerve palsy examination to facilitate 
appropriate NIHSS evaluation [2]. The introduction of masks 
and antigen testing in our stroke centres improved the in-hos-
pital flow of patients and boosted the sense of safety among 
staff. However, exact data on how these measures affected 
quality metrics in stroke care is lacking.
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Table 1. Clinical characteristics of studied cohort
Pre-COVID-19 COVID-19 P
n (%) 233 (55.6) 186 (44.4)  
Sex (F) n (%)* 124 (53.2) 88 (47.3) 0.2
Age mean (± SD)* 71.9 (13.6) 69.8 (13) 0.1
Acute cerebrovascular incident admissions/100,000 inhabitants in study period 29.125 23.25 0.04
Reason for acute cerebrovascular hospital admission
TIA 45 (19.3) 20 (10.7) 0.01
non-TIA 188 (80.7) 166 (89.2) -
Ischaemic stroke 170 (72.9) 153 (82.2) 0.2
Intracerebral haemorrhage 18 (7.7) 11 (5.9) 0.2
SAH 0 2 (1) -
Ischaemic stroke aetiology
LAD 50 (23.2) 46 (26.13) 0.2
CS 68 (31.6) 42 (23.8) -
SVD 48 (22.3) 47 (26.7) -
LVO** 77 (33) 56 (30) 0.7
Intravenous rtPA 68 (29.2) 54 (29) 0.9
DTN 29.7 (21) 48 (23.5) < 0.01
DTCT 25.9 (10) 37.7 (25) < 0.01
rtPA+ mechanical thrombectomy  27 (11.6) 30 (16) 0.1
Mechanical thrombectomy  39 (16.7) 34 (18.3) 0.6
NIHSS>8 p 77 (45) 71 (47) 0.9
NIHSS admission 11.9 (8) 10.2 (7) 0.05
NIHSS discharge 6.3 (7) 4.9 (5) 0.06
mRS discharge 3.3 (2) 3.1 (2) 0.2
mRS admission 4.2 (3) 4.4 (2) 0.6
mRS 30 day 4.3 (2) 4.6 (2) 0.4
30-day mortality 35 (15) 21 (11.5) 0.7
DTCT 27.1 (10) 41.2 (27) 0.04
DTG (drip-and-ship) 35 (41) 73 (76) 0.04
DTG (mothership) 75.9 (56) 123.7 (75) 0.03
OTG (all patients) 223 (71) 259 (80) < 0.01
OTG (drip-and-ship) 240 (69) 293 (51) 0.01
OTG (mothership) 203 (74) 232 (104) 0.04
Effective recanalisation (2b, 3) n (%) 27 (73) 24 (88.8) 0.11
30-day mortality n (%) 9 (24) 9 (28) 0.7
30-day mRS mean (±SD) 3.8 (2.1) 2.9 (2.4) 0.14
NIHSS admission 17 (6) 15.5 (5) 0.1
NIHSS discharge mean (±SD) 11 (10) 6.3 (4.1) 0.02
*Data expressed as means (± SD) or numbers (%); **vs. no LVO; TIA — transient ischaemic attack; SAH — subarachnoid haemorrhage; LAD — large artery atherothrombotic disease; CS — cryptogenic stroke; 
SVD — cerebral small vessel disease; LVO — large vessel occlusion;  rtPA — recombinant tissue plasminogen activator; DTN — door-to-needle; DTCT — door-to-computed tomography; NIHSS — National 
Institutes of Health Stroke Scale; mRS — modified Rankin scale; DTG — door-to-groin; OTG — onset-to-groin
Mechanical thrombectomy is provided in Poland via two main 
organisational paradigms: the mothership, in which the patient is 
directly brought to a CSC, and the drip-and-ship model, in which 
initial assessment and eventual thrombolytic treatment at the pri-
mary stroke centres are followed by ‘shipping’ out to a CSC. The 
choice of one model over the other implies clinical consequences 
for treated patients as well as for local health policies, including 
the distribution of hospital facilities over the region of interest. 
Our data shows that the mothership model provided signifi-
cantly shorter OTG delays, of more than one hour. This may indicate 
that it might be considered the model of choice during the pan-
demic. Avoidance of additional triage in overcrowded emergency 
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departments, and arranging transport, both of which are necessary 
in the drip-and-ship model, could prevent delays caused by a lack of 
resources that are otherwise engaged in COVID-19 care. 
In November and December 2020, Poland’s healthcare 
system struggled with the second wave of the coronavirus 
pandemic, with the number of new daily cases reaching over 
27,000, and a national quarantine was expected. The limitation 
of the presented study is that the results might not be repre-
sentative of other regions of Poland. Although we did not find 
a significant difference in stroke outcomes between patients 
treated during the COVID-19 and pre-COVID-19 periods, 
this might have been related to limited sample size. The reason 
for the difference in the number of stroke admissions between 
the weeks of the COVID-19 pandemic and the frequency of 
recent TIA in patients hospitalised due to stroke have not been 
analysed in our study, so a follow-up study looking at these 
metrics in the second wave would be important. 
However, due to the limited number of other studies, our 
data might be important in terms of optimising acute stroke 
care before a third wave and until a COVID-19 vaccine be-
comes widely available.
Future directions
Our study shows that even countries less affected by the 
COVID-19 pandemic during the first wave, such as Poland, 
experienced collateral adverse effects on stroke-care quality 
metrics. The onset of the COVID-19 pandemic was correlat-
ed with a reduction in the number of admissions to stroke 
departments, and resulted in a significant increase in stroke 
interventional treatment delays. To combat this trend, optimis-
ing healthcare resources before subsequent pandemic waves 
is necessary. These actions should include reorganisation of 
the stroke-care network, with promotion of the mothership 
paradigm; the development of new in-hospital care pathways 
based on continuous analysis of local data; and nationwide 
education campaigns about the importance of immediate 
response to stroke and TIA symptoms. Moreover, a campaign 
is required to reassure patients that hospitals provide safe 
in-person medical care in cases of alarming symptoms. 
As these findings are preliminary conclusions from our 
data, the full impact of the COVID-19 pandemic on stroke 
management in Poland still needs to be evaluated. Further-
more, studies evaluating the impact of peri-stroke COV-
ID-19 on the risk and aetiology of stroke are needed. 
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